Walgreens Boots Alliance, Inc.
WBA33.82
Walgreens Boots Alliance, Inc.
NASDAQ:WBA
RECENT
PRICE
33.82
P/E
RATIO
-10.10
(PEG:- -)
P/E RATIO
RELATIVE
TO S&P
-0.48
DIV
YLD
5.12%
High:
Low:
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Legends
Stock price
0.72 Beta (1.0 Market)
0
0
0
0
0
0
0
0
0
% total return 03/23:
Stock
S&P
1y.
0
0
3y.
0
0
5y.
0
0
0
Percent shares traded:
0
0
0
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
Fiscal year
53.84
2.04
0.57
0.31
59.59
2.18
0.82
0.38
63.97
2.03
2.21
0.45
68.68
2.13
2.78
0.55
78.88
2.97
2.66
0.71
81.89
2.43
3.29
0.90
76.34
2.59
3.27
1.10
80.15
2.03
2.92
1.26
99.16
4.05
4.23
1.33
108.35
3.85
6.02
1.44
110.12
3.80
5.50
1.61
132.73
5.07
6.96
1.75
148.53
4.32
4.22
1.78
158.67
0.52
4.67
1.99
153.23
2.94
4.83
1.87
153.52
5.02
2.50
1.92
153.01
(3.99)
1.62
1.92
Revenue per share
Earnings per share
Free Cash Flow per sh
Dividends per share
1.79
11.12
2.25
12.99
1.95
14.52
1.03
14.67
1.33
16.22
1.77
20.85
1.28
20.56
1.16
21.46
1.20
29.58
1.22
27.59
1.26
25.59
1.38
26.24
1.85
25.51
1.56
23.47
1.59
27.08
2.01
33.97
2.19
30.94
CAPEX per share
Book Value per share
999
991
990
982
915
875
946
953
1,043
1,083
1,074
991
922
879
865
864
864
Comm.Shares outs.(m)
14.4
0.8
1.1%
10.2
0.5
1.7%
10.8
0.2
2.1%
11.0
0.5
2.4%
9.4
0.6
2.5%
10.3
0.7
3.6%
14.4
0.8
2.9%
25.6
1.4
2.4%
21.0
1.0
1.6%
21.2
1.0
1.8%
20.8
0.9
2.0%
13.9
0.6
2.5%
13.6
0.6
3.0%
82.5
2.2
4.6%
17.0
0.6
3.7%
8.3
0.4
4.6%
(10.1)
(0.5)
5.1%
Avg. annual P/E ratio
P/E relative to S&P500
Avg. annual div. yield
Capital Structure (30/11/22 | Q1)
Total liabilities
$68,293 m.
Total assets
$92,875 m.
Long-term debt
$29,303 m.
Cash and equiv.
$2,349 m.
Goodwill $22,582 m.
Retained earnings $37,811 m.
Common stock 864 m. shares
Market Capitalisation
$28,834 m. (as of 29/3/23)
71,633
4.8%
72,217
5.5%
76,392
5.5%
103,444
4.5%
117,351
5.1%
118,214
4.7%
131,537
4.9%
136,866
3.7%
139,537
0.9%
132,509
1.8%
132,703
1.0%
132,184
(4.6)%
Revenue (m)
Operating margin
1,166
2,127
1,283
2,450
1,316
1,932
1,742
4,220
1,718
4,173
1,654
4,078
1,770
5,024
2,038
3,982
1,927
456
1,973
2,542
1,990
4,337
1,985
(3,436)
Depreciation (m)
Net profit (m)
37.0%
3.0%
37.1%
3.4%
42.9%
2.5%
19.9%
4.1%
19.4%
3.6%
15.7%
3.4%
16.7%
3.8%
13.0%
2.9%
48.5%
0.3%
33.4%
1.9%
0.7%
3.3%
324.6%
(2.6)%
Income tax rate
Net profit margin
2,038
4,073
18,236
2,991
4,477
19,454
3,347
3,736
20,457
3,100
13,315
30,861
8,870
18,705
29,880
1,206
12,684
27,466
(3,821)
12,431
26,007
(7,069)
11,098
23,512
(8,997)
12,203
20,637
(6,240)
29,828
23,419
(5,681)
32,132
29,366
(8,513)
29,303
24,582
Working capital (m)
Long-term debt (m)
Equity (m)
8.8%
10.4%
11.7%
9.6%
11.4%
12.6%
7.3%
9.7%
9.4%
9.1%
8.6%
13.7%
8.4%
8.0%
14.0%
10.0%
8.5%
14.8%
12.1%
9.8%
19.3%
11.1%
7.9%
16.9%
1.3%
1.7%
2.2%
4.7%
5.1%
10.9%
7.0%
5.3%
14.8%
4.9%
(1.5)%
(14.0)%
ROIC
Return on capital
Return on equity
Working Capital
2020
2021
2022
Cash assets
516
1,193
1,358
Receivables
7,132
5,663
5,017
Inventory
9,451
8,159
8,353
Other
974
799
1,060
Current assets
18,073
15,814
16,902
Acc. Payable
14,458
11,136
11,255
Debt due
5,965
3,565
3,345
Other
6,647
7,353
7,983
Current liab.
27,070
22,054
22,583
63.0%
68.7%
57.6%
53.6%
37.9%
68.3%
67.2%
59.1%
62.5%
41.6%
57.7%
117.7%
65.4%
101.0%
58.7%
149.1%
(283.1)%
81.2%
36.4%
41.4%
59.2%
76.6%
149.9%
- -
Plowback ratio
Div.&Repurch. to FCF
Walgreens Boots Alliance, Inc. (US) started trading on December 3, 2014 (cik: 0001618921), operates in the Healthcare sector (Pharmaceutical Retailers industry), has 325,000 full-time employees, and is led by Ms. Rosalind Gates Brewer. Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Annual rates
(avg rate of change)
Past
5 y.
Past
10 y.
Revenues
0.28%
7.53%
Cash flow
-21.13%
2.13%
Earnings
104.70%
59.54%
Dividends
-1.01%
5.64%
Book value
4.26%
6.28%
Insider trading
Type
Shares
Date
Lederer John Anthony
Award
822
01/26/23
Jarrett Valerie B
Award
685
01/26/23
Murphy Dominic
Award
685
01/26/23
Ban Kevin M.
Exempt
10,303
11/18/22
Ban Kevin M.
Sale
10,303
11/18/22
Fiscal Year Ends
Quarterly Revenue (m)
Full fiscal year
I
II
III
IV
2021
36,307
32,779
34,030
34,262
137,378
2022
33,901
33,756
32,597
32,449
132,703
2023
33,382
- -
- -
- -
- -
Fiscal Year Ends
Earnings per share
Full fiscal year
I
II
III
IV
2021
(0.36)
1.19
1.38
0.73
2.94
2022
4.14
1.02
0.33
(1.03)
4.47
2023
(4.31)
- -
- -
- -
- -
Fiscal Year Ends
Quarterly dividends paid
Full fiscal year
I
II
III
IV
2021
0.47
0.47
0.47
0.47
1.87
2022
0.48
0.49
0.48
0.47
1.92
2023
0.48
- -
- -
- -
- -
02/19/2023
Walgreens CEO Bets on Doctors Over Drugstores in Search for Growth
The Wall Street Journal - Read more...
02/13/2023
Opioid Settlement Money Is Coming. Two Ohio Counties Differ on How to Spend It.
The Wall Street Journal - Read more...
01/05/2023
Walgreens Sales Fall as Demand for Covid Vaccines Wanes
The Wall Street Journal - Read more...
01/05/2023
Walgreens Becomes First U.S. Pharmacy Chain to Say It Will Sell Abortion Pill
The Wall Street Journal - Read more...
11/07/2022
Walgreens Unit Strikes Roughly $9 Billion Deal With Summit Health
The Wall Street Journal - Read more...
11/02/2022
CVS, Walgreens to Pay More Than $10 Billion to Settle Opioid Lawsuits
The Wall Street Journal - Read more...
09/20/2022
Walgreens to Take Full Ownership of Shields Health
The Wall Street Journal - Read more...
08/17/2022
CVS, Walgreens and Walmart Ordered to Pay $650 Million to Ohio Counties in Opioid Case
The Wall Street Journal - Read more...
08/11/2022
Walgreens Offers Bonuses Up to $75,000 to Recruit Pharmacists
The Wall Street Journal - Read more...
08/10/2022
Walgreens Helped Fuel San Francisco Opioid Epidemic, Judge Rules
The Wall Street Journal - Read more...
07/08/2022
Higher Financing Costs, Lower Valuations Crimp M&A
The Wall Street Journal - Read more...
06/30/2022
Walgreens Profit Shrinks After Opioid Deal, Fewer Vaccinations
The Wall Street Journal - Read more...
05/04/2022
Walgreens Names Heads of Marketing, Merchandising and Product
The Wall Street Journal - Read more...
04/27/2022
Walmart, CVS Block or Delay Telehealth Adderall Prescriptions
The Wall Street Journal - Read more...
03/31/2022
Walgreens Posts Higher Sales, Powered by Covid-19 Vaccine, Testing Demand
The Wall Street Journal - Read more...
01/14/2022
Walgreens, CVS Shut Some Pharmacies on Weekends as Omicron Strains Staffing
The Wall Street Journal - Read more...
01/06/2022
Walgreens Posts Higher Sales and Profit From Covid-19 Demand
The Wall Street Journal - Read more...
01/06/2022
Bitcoin, Bed Bath & Beyond, Walgreens, Exxon: What to Watch in the Stock Market Today
The Wall Street Journal - Read more...
11/24/2021
Walgreens, Walmart, CVS Contributed to Opioid Epidemic, Ohio Jury Finds
The Wall Street Journal - Read more...
10/14/2021
Walgreens to Invest $5.2 Billion in VillageMD
The Wall Street Journal - Read more...
10/14/2021
Morgan Stanley, Citigroup, Plug Power: What to Watch in the Stock Market Today
The Wall Street Journal - Read more...
10/14/2021
Retailers Vetted Theranos Without Testing Devices
The Wall Street Journal - Read more...
09/24/2021
Pharmacies Prepare for Broader Covid-19 Booster Distribution
The Wall Street Journal - Read more...
09/15/2021
Biden Meets With Executives on Vaccine Mandate
The Wall Street Journal - Read more...
07/01/2021
Walgreens Sales Rise as Vaccinations Improve Prescriptions Business
The Wall Street Journal - Read more...
07/01/2021
Krispy Kreme, Micron Technology, CureVac: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
03/31/2021
Walgreens Reports Stronger Profit as Covid-19 Vaccine Rollout Ramps Up
The Wall Street Journal - Read more...
03/31/2021
Chewy, Deliveroo and Credit Suisse: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...